echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > FDA warns of caution over use of radiofrequency ablation meter to treat lung tumors

    FDA warns of caution over use of radiofrequency ablation meter to treat lung tumors

    • Last Update: 2020-07-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    the U.SFDA recently warned medical personnel that the use of radiofrequency ablation in lungtumorablation has been reported to cause patient deathsThe patient's death may be related to the patient's choice, follow-up treatment, and the technology used in radiofrequency instruments, including placement and operationAlthough the rfradioagulant's certification was approved for coagulation of soft tissue necrosis through heat, it was not approved for lungtumorablationThe FDA reminds medical personnel to exercise caution when operating RF ablers and to strictly follow the operating instructions, manufacturer's instructions and any operational training requirements
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.